The Government's commitment to clinical governance has been established in the White Paper entitled "A First Class Service: Quality in the new NHS". There are several definitions of clinical governance but the simplest I have seen is in the paper on Clinical Governance in Northern Ireland "Corporate Accountability for clinical performance". In Northern Ireland we are being allowed to lag behind the introduction of clinical governance in England and Wales which occurred on 1st April, 1999 . The British Association of Medical Managers has produced a paper on Clinical Governance in which it highlights the very important role of Continuing Medical Education (CME) and Continuing Professional Development (CPD) in assuring the quality of medical care. The GMC has just announced that it intends to have fiveyearly reviews of specialists' continuing competence to practise but it has not made clear how this will be achieved. The Royal Colleges have for some years past been recording the CME activities of their fellows and members but none has made any serious impact on the ability of non-compliant practitioners to continue to practise. Questions have been raised about the current system of "clocking" up the hours with no assessment as to their effectiveness. There In the context of business management which pervades our current health service, it is accepted that the money for CME must come from somewhere. The Department of Health in its guidance on contracting has stated that CME/ CPD is a "quality" issue and as such is a legitimate additonal price which can be charged to commissioners. The commissioners for their part accept this principle but state they have to live within tightly constrained budgets and that, if more of their funding goes for CME/CPD, there will be less available for treating patients. The Government has a political objective to reduce waiting lists and wishes to see any additional funding they are providing going directly to increased activity. We have a particular problem on our small island, namely the high cost of travel to meetings. A survey in 1995 by the NICSC gave firm evidence that hospital trusts were not reimbursing consultants with the full cost of attending national and international conferences. There was considerable reliance on the pharmaceutical industry to attain CME 'points' and questions of probity are obvious.
C) The Ulster Medical Society, 1999. In many other health service regions financial provision is made for assisted reproduction, resulting in a 'baby-by-postcode' scenario. However, in these areas funding is often severely limited. For example, couples over 35 years old are often excluded as are those where one or other partner already has a child. This system offunding is not equitable either. If there must be funding restrictions, and this seems inevitable as there is no area of medicine with unlimited funding, perhaps it would be better if authorities decided to spend an annual sum on the provision of
